Good writeup in Friday's AFR mentioning IMM and take overs, but it does mention that biotechs usually raise after results.
I reckon its coming.
Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC, page-94
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.3¢ |
Change
0.003(0.78%) |
Mkt cap ! $469.0M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 33.0¢ | 31.8¢ | $522.6K | 1.615M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 425141 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 228465 | 49 |
View Market Depth
| Last trade - 14.51pm 14/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |